Accès ouvert · CC BY

B1.12: a novel peptide interacting with the extracellular loop of the EBV oncoprotein LMP1

Article scientifique 2019 Sciences de la santé Anglais

Résumé

Latent membrane protein 1 (LMP1) encoded by the Epstein-Barr virus (EBV) plays an important role in EBV-induced cell transformation. Down-regulation of the LMP1 expression had shown promising results on cancer cell therapy. In this study, we identified by Phage display a novel peptide called B1.12 (ACPLDLRSPCG) which selectively binds to the extracellular loop (B1) of the LMP1 oncoprotein as demonstrated by molecular docking, NMR and ITC. Using an LMP1 expressing cell line, we showed that B1.12 decreased cell viability, and induced G0/G1 cell cycle arrest. In addition, the expression of A20, pAkt, and pNFkb (pRelA536) in C666-1 cells treated with B1.12 decreased compared to the untreated cells. In conclusion, we selected a novel peptide able to bind specifically to the extracellular loop of LMP1 and thus modulate its oncogenic properties.

Citer ce document

Ammous-Boukhris, N., Mosbah, A., Ayadi, W., Sahli, E., Chevance, S., Bondon, A., Gargouri, A., Baudy-Floc’h, M., & Mokdad‐Gargouri, R. (2019). B1.12: a novel peptide interacting with the extracellular loop of the EBV oncoprotein LMP1. Scientific Reports. https://doi.org/10.1038/s41598-019-39732-y

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 01/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 14

Téléchargements (hors robots) : 0

Méthode de comptage